Korea Type 1 Diabetes (T1D) Market Report

Europe Korea Type 1 Diabetes (T1D) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Mar 09, 2020
  • PAGES：189
  • REPORT CODE：GMM500272
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Korea Type 1 Diabetes (T1D) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Korea Type 1 Diabetes (T1D) Market Segmentations:

    By Player:

    • Boehringer Ingelheim

    • Astellas

    • Bristol-Myers Squibb

    • Sanofi

    • Merck

    • Samsung Bioepis

    • Janssen

    • Eli Lilly

    • Novo Nordisk

    • Lexicon

    • Novo Nordisk

    • Biocon

    By Type:

    • Rapid Acting Insulin Analogs

    • Long Acting Insulin Analogs

    • Premix Insulin Analogs

    By End-User:

    • Premix Insulin Analogs

    • Premix Insulin Analogs

    • Premix Insulin Analogs

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Korea Type 1 Diabetes (T1D) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2014 to 2026

    • 1.3.2 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2014 to 2026

    • 1.3.3 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • 1.4.2 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • 1.4.3 Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Korea Type 1 Diabetes (T1D) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Korea Type 1 Diabetes (T1D) by Major Types

      • 3.4.1 Market Size and Growth Rate of Rapid Acting Insulin Analogs

      • 3.4.2 Market Size and Growth Rate of Long Acting Insulin Analogs

      • 3.4.3 Market Size and Growth Rate of Premix Insulin Analogs

    4 Segmentation of Korea Type 1 Diabetes (T1D) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Korea Type 1 Diabetes (T1D) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Korea Type 1 Diabetes (T1D) for Premix Insulin Analogs

      • 4.4.2 Market Size and Growth Rate of Korea Type 1 Diabetes (T1D) for Premix Insulin Analogs

      • 4.4.3 Market Size and Growth Rate of Korea Type 1 Diabetes (T1D) for Premix Insulin Analogs

    5 Market Analysis by Major Regions

    • 5.1 Europe Korea Type 1 Diabetes (T1D) Production Analysis by Top Regions

    • 5.2 Europe Korea Type 1 Diabetes (T1D) Consumption Analysis by Top Regions

    • 5.3 Europe Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Korea Type 1 Diabetes (T1D) Market among Top Countries

    • 6.1 Top 5 Export Countries in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 7.1 Germany Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 7.2 Germany Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    8. UK Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 8.1 UK Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 8.2 UK Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    9. France Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 9.1 France Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 9.2 France Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    10. Italy Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 10.1 Italy Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 10.2 Italy Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    11. Spain Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 11.1 Spain Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 11.2 Spain Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    12. Poland Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 12.1 Poland Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 12.2 Poland Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    13. Russia Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 13.1 Russia Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 13.2 Russia Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    14. Switzerland Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 14.1 Switzerland Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 14.2 Switzerland Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    15. Turkey Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 15.1 Turkey Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 15.2 Turkey Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.2 Finland Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.3 Norway Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.4 Sweden Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 16.3.6 Iceland Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 17.3.2 Netherlands Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 18.3.2 Latvia Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

      • 18.3.3 Lithuania Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Boehringer Ingelheim

      • 19.1.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Astellas

      • 19.2.1 Astellas Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Bristol-Myers Squibb

      • 19.3.1 Bristol-Myers Squibb Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sanofi

      • 19.4.1 Sanofi Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Merck

      • 19.5.1 Merck Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Samsung Bioepis

      • 19.6.1 Samsung Bioepis Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Janssen

      • 19.7.1 Janssen Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Eli Lilly

      • 19.8.1 Eli Lilly Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Novo Nordisk

      • 19.9.1 Novo Nordisk Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Lexicon

      • 19.10.1 Lexicon Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Novo Nordisk

      • 19.11.1 Novo Nordisk Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Biocon

      • 19.12.1 Biocon Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 79 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Rapid Acting Insulin Analogs from 2014 to 2026

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Long Acting Insulin Analogs from 2014 to 2026

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • Figure Europe Korea Type 1 Diabetes (T1D) Market Size and Growth Rate of Premix Insulin Analogs from 2014 to 2026

    • Figure Germany Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure France Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Korea Type 1 Diabetes (T1D) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Korea Type 1 Diabetes (T1D) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Korea Type 1 Diabetes (T1D)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Korea Type 1 Diabetes (T1D) by Different Types from 2014 to 2026

    • Table Consumption Share of Korea Type 1 Diabetes (T1D) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rapid Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Long Acting Insulin Analogs

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Korea Type 1 Diabetes (T1D) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Korea Type 1 Diabetes (T1D) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Figure Market Size and Growth Rate of Premix Insulin Analogs

    • Table Europe Korea Type 1 Diabetes (T1D) Production by Major Regions

    • Table Europe Korea Type 1 Diabetes (T1D) Production Share by Major Regions

    • Figure Europe Korea Type 1 Diabetes (T1D) Production Share by Major Countries and Regions in 2014

    • Table Europe Korea Type 1 Diabetes (T1D) Consumption by Major Regions

    • Table Europe Korea Type 1 Diabetes (T1D) Consumption Share by Major Regions

    • Table Germany Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table UK Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table France Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Italy Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Spain Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Poland Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Russia Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Switzerland Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Turkey Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Korea Type 1 Diabetes (T1D) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Germany Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Germany Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Germany Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table UK Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table UK Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table UK Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table UK Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table France Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table France Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table France Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table France Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Italy Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Italy Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Italy Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Spain Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Spain Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Spain Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Poland Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Poland Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Poland Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Russia Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Russia Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Russia Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Switzerland Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Turkey Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Turkey Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Turkey Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Korea Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Korea Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Korea Type 1 Diabetes (T1D) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Korea Type 1 Diabetes (T1D) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Samsung Bioepis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepis

    • Figure Sales and Growth Rate Analysis of Samsung Bioepis

    • Figure Revenue and Market Share Analysis of Samsung Bioepis

    • Table Product and Service Introduction of Samsung Bioepis

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Lexicon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lexicon

    • Figure Sales and Growth Rate Analysis of Lexicon

    • Figure Revenue and Market Share Analysis of Lexicon

    • Table Product and Service Introduction of Lexicon

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US